Using human induced pluripotent stem cells to treat retinal disease

Progress in Retinal and Eye Research

Volumn 37, Issue , 2013, Pages 163-181

  Borooah, S ^a,e   Phillips, M J ^b   Bilican, B ^a   Wright, A F ^c   Wilmut, I ^a   Chandran, S ^a   Gamm, D ^b,d   Dhillon, B ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

IPS; Pluripotent; Reprogramming; Retina; Stem cells

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NICOTINAMIDE; NOGGIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

BLINDNESS; CELL DIFFERENTIATION; CELL SELECTION; CELL STRUCTURE; CELL TRANSPLANTATION; CHROMOSOME ABERRATION; CLINICAL PROTOCOL; DISEASE MODEL; DRUG SCREENING; EPIGENETICS; HUMAN; HUMAN CELL; NONHUMAN; PHOTORECEPTOR; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETINA CELL; RETINA DISEASE; REVIEW; SEQUENCE ANALYSIS; SOMATIC CELL;

IPS; PLURIPOTENT; REPROGRAMMING; RETINA; STEM CELLS;

HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; REGENERATIVE MEDICINE; RETINAL DISEASES; STEM CELL TRANSPLANTATION;

EID: 84887357405     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2013.09.002     Document Type: Review

References (166)

1. Aasen T., Raya A., Barrero M.J., Garreta E., Consiglio A., Gonzalez F., Vassena R., Bilic J., Pekarik V., Tiscornia G., Edel M., Boue S., Izpisua Belmonte J.C. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26:1276-1284.
2. Bae D., Mondragon-Teran P., Hernandez D., Ruban L., Mason C., Bhattacharya S.S., Veraitch F.S. Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. Stem Cells Dev. 2012, 21:1344-1355.
3. Balse E., Tessier L.H., Fuchs C., Forster V., Sahel J.A., Picaud S. Purification of mammalian cone photoreceptors by lectin panning and the enhancement of their survival in glia-conditioned medium. Invest. Ophthalmol. Vis. Sci. 2005, 46:367-374.
4. Bar-Nur O., Russ H.A., Efrat S., Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 2011, 9:17-23.
5. Barber A.C., Hippert C., Duran Y., West E.L., Bainbridge J.W., Warre-Cornish K., Luhmann U.F., Lakowski J., Sowden J.C., Ali R.R., Pearson R.A. Repair of the degenerate retina by photoreceptor transplantation. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:354-359.
6. Ben-David U., Mayshar Y., Benvenisty N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 2011, 9:97-102.
7. Bharti K., Miller S.S., Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011, 24:21-34.
8. Bilican B., Serio A., Barmada S.J., Nishimura A.L., Sullivan G.J., Carrasco M., Phatnani H.P., Puddifoot C.A., Story D., Fletcher J., Park I.H., Friedman B.A., Daley G.Q., Wyllie D.J., Hardingham G.E., Wilmut I., Finkbeiner S., Maniatis T., Shaw C.E., Chandran S. Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci. Transl. Med. 2013, 5:188l-1182.
9. Bock C., Kiskinis E., Verstappen G., Gu H., Boulting G., Smith Z.D., Ziller M., Croft G.F., Amoroso M.W., Oakley D.H., Gnirke A., Eggan K., Meissner A. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011, 144:439-452.
10. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
11. Buchholz D.E., Hikita S.T., Rowland T.J., Friedrich A.M., Hinman C.R., Johnson L.V., Clegg D.O. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009, 27:2427-2434.
12. Buchholz D.E., Pennington B.O., Croze R.H., Hinman C.R., Coffey P.J., Clegg D.O. Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl. Med. 2013, 2:384-393.
13. Byrne J.A., Nguyen H.N., Reijo Pera R.A. Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One 2009, 4:e7118.
14. Carr A.J., Vugler A.A., Hikita S.T., Lawrence J.M., Gias C., Chen L.L., Buchholz D.E., Ahmado A., Semo M., Smart M.J., Hasan S., da Cruz L., Johnson L.V., Clegg D.O., Coffey P.J. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009, 4:e8152.
15. Cermak T., Doyle E.L., Christian M., Wang L., Zhang Y., Schmidt C., Baller J.A., Somia N.V., Bogdanove A.J., Voytas D.F. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011, 39:e82.
16. Chambers S.M., Fasano C.A., Papapetrou E.P., Tomishima M., Sadelain M., Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27:275-280.
17. Chan E.M., Ratanasirintrawoot S., Park I.H., Manos P.D., Loh Y.H., Huo H., Miller J.D., Hartung O., Rho J., Ince T.A., Daley G.Q., Schlaeger T.M. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 2009, 27:1033-1037.
18. Chen G., Gulbranson D.R., Hou Z., Bolin J.M., Ruotti V., Probasco M.D., Smuga-Otto K., Howden S.E., Diol N.R., Propson N.E., Wagner R., Lee G.O., Antosiewicz-Bourget J., Teng J.M., Thomson J.A. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 2011, 8:424-429.
19. Chen M., Huang J., Yang X., Liu B., Zhang W., Huang L., Deng F., Ma J., Bai Y., Lu R., Huang B., Gao Q., Zhuo Y., Ge J. Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One 2012, 7:e28203.
20. Cheong H.T., Takahashi Y., Kanagawa H. Birth of mice after transplantation of early cell-cycle-stage embryonic nuclei into enucleated oocytes. Biol. Reprod. 1993, 48:958-963.
21. Cimadamore F., Curchoe C.L., Alderson N., Scott F., Salvesen G., Terskikh A.V. Nicotinamide rescues human embryonic stem cell-derived neuroectoderm from parthanatic cell death. Stem Cells 2009, 27:1772-1781.
22. Cyranoski D. Stem cells cruise to clinic. Nature 2013, 494:413.
23. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
24. Davis R.L., Cheng P.F., Lassar A.B., Thayer M., Tapscott S., Weintraub H. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis. Princess Takamatsu Symp. 1989, 20:267-278.
25. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007, 10:608-614.
26. Diniz B., Thomas P.B., Ribeiro R.M., Hu Y., Fernandes R.B., Ahuja A., Zhu D., Liu L., Koss M., Maia M., Chader G.J., Hinton D., Thomas B.B., Humayun M. Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells - improved survival when implanted as a monolayer. Invest. Ophthalmol. Vis. Sci. 2013, 54:5087-5096.
27. Eberle D., Schubert S., Postel K., Corbeil D., Ader M. Increased integration of transplanted CD73-positive photoreceptor precursors into adult mouse retina. Invest. Ophthalmol. Vis. Sci. 2011, 52:6462-6471.
28. Eiraku M., Takata N., Ishibashi H., Kawada M., Sakakura E., Okuda S., Sekiguchi K., Adachi T., Sasai Y. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011, 472:51-56.
29. Eminli S., Foudi A., Stadtfeld M., Maherali N., Ahfeldt T., Mostoslavsky G., Hock H., Hochedlinger K. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat. Genet. 2009, 41:968-976.
30. Erecinska M., Silver I.A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir. Physiol. 2001, 128:263-276.
31. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., Li W., Weng Z., Chen J., Ni S., Chen K., Li Y., Liu X., Xu J., Zhang S., Li F., He W., Labuda K., Song Y., Peterbauer A., Wolbank S., Redl H., Zhong M., Cai D., Zeng L., Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010, 6:71-79.
32. Fusaki N., Ban H., Nishiyama A., Saeki K., Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2009, 85:348-362.
33. Gamm D.M., Melvan J.N., Shearer R.L., Pinilla I., Sabat G., Svendsen C.N., Wright L.S. Anovel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2008, 49:788-799.
34. Garita-Hernandez M., Diaz-Corrales F., Lukovic D., Guede I.G., Lloret A.D., Sanchez M.L., Massalini S., Erceg S., Bhattacharya S.S. Hypoxia increases the yield of photoreceptors differentiating from mouse embryonic stem cells and improves the modeling of retinogenesis invitro. Stem Cells 2013.
35. Geti I., Ormiston M.L., Rouhani F., Toshner M., Movassagh M., Nichols J., Mansfield W., Southwood M., Bradley A., Rana A.A., Vallier L., Morrell N.W. Apractical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells. Stem Cells Transl. Med. 2012, 1:855-865.
36. Giorgetti A., Montserrat N., Aasen T., Gonzalez F., Rodriguez-Piza I., Vassena R., Raya A., Boue S., Barrero M.J., Corbella B.A., Torrabadella M., Veiga A., Izpisua Belmonte J.C. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 2009, 5:353-357.
37. Gonzalez-Cordero A., West E.L., Pearson R.A., Duran Y., Carvalho L.S., Chu C.J., Naeem A., Blackford S.J., Georgiadis A., Lakowski J., Hubank M., Smith A.J., Bainbridge J.W., Sowden J.C., Ali R.R. Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nat. Biotechnol. 2013, 31:741-747.
38. Gotz M., Huttner W.B. The cell biology of neurogenesis. Nat. Rev. Mol. Cell. Biol. 2005, 6:777-788.
39. Gourraud P.A., Gilson L., Girard M., Peschanski M. The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines. Stem Cells 2012, 30:180-186.
40. Gundry R.L., Riordon D.R., Tarasova Y., Chuppa S., Bhattacharya S., Juhasz O., Wiedemeier O., Milanovich S., Noto F.K., Tchernyshyov I., Raginski K., Bausch-Fluck D., Tae H.J., Marshall S., Duncan S.A., Wollscheid B., Wersto R.P., Rao S., Van Eyk J.E., Boheler K.R. Acell surfaceome map for immunophenotyping and sorting pluripotent stem cells. Mol. Cell. Proteomics 2012, 11:303-316.
41. Gurdon J.B. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J.Embryol. Exp. Morphol. 1962, 10:622-640.
42. Gust J., Reh T.A. Adult donor rod photoreceptors integrate into the mature mouse retina. Invest. Ophthalmol. Vis. Sci. 2011, 52:5266-5272.
43. Hambright D., Park K.Y., Brooks M., McKay R., Swaroop A., Nasonkin I.O. Long-term survival and differentiation of retinal neurons derived from human embryonic stem cell lines in un-immunosuppressed mouse retina. Mol. Vis. 2012, 18:920-936.
44. Han D.W., Tapia N., Hermann A., Hemmer K., Hoing S., Arauzo-Bravo M.J., Zaehres H., Wu G., Frank S., Moritz S., Greber B., Yang J.H., Lee H.T., Schwamborn J.C., Storch A., Scholer H.R. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 2012, 10:465-472.
45. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462:595-601.
46. Hirai H., Katoku-Kikyo N., Karian P., Firpo M., Kikyo N. Efficient iPS cell production with the MyoD transactivation domain in serum-free culture. PLoS One 2012, 7:e34149.
47. Hirami Y., Osakada F., Takahashi K., Okita K., Yamanaka S., Ikeda H., Yoshimura N., Takahashi M. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci. Lett. 2009, 458:126-131.
48. Howden S.E., Gore A., Li Z., Fung H.L., Nisler B.S., Nie J., Chen G., McIntosh B.E., Gulbranson D.R., Diol N.R., Taapken S.M., Vereide D.T., Montgomery K.D., Zhang K., Gamm D.M., Thomson J.A. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6537-6542.
49. Hu Q., Friedrich A.M., Johnson L.V., Clegg D.O. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 2010, 28:1981-1991.
50. Hu Y., Liu L., Lu B., Zhu D., Ribeiro R., Diniz B., Thomas P.B., Ahuja A.K., Hinton D.R., Tai Y.C., Hikita S.T., Johnson L.V., Clegg D.O., Thomas B.B., Humayun M.S. Anovel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res. 2012, 48:186-191.
51. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A.E., Melton D.A. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 2008, 26:795-797.
52. Idelson M., Alper R., Obolensky A., Ben-Shushan E., Hemo I., Yachimovich-Cohen N., Khaner H., Smith Y., Wiser O., Gropp M., Cohen M.A., Even-Ram S., Berman-Zaken Y., Matzrafi L., Rechavi G., Banin E., Reubinoff B. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009, 5:396-408.
53. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
54. Inoue Y., Iriyama A., Ueno S., Takahashi H., Kondo M., Tamaki Y., Araie M., Yanagi Y. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp. Eye Res. 2007, 85:234-241.
55. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., Soreq H., Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000, 6:88-95.
56. Itzhaki I., Maizels L., Huber I., Zwi-Dantsis L., Caspi O., Winterstern A., Feldman O., Gepstein A., Arbel G., Hammerman H., Boulos M., Gepstein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011, 471:225-229.
57. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132:567-582.
58. Jin Z.B., Okamoto S., Osakada F., Homma K., Assawachananont J., Hirami Y., Iwata T., Takahashi M. Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 2011, 6:e17084.
59. Judson R.L., Babiarz J.E., Venere M., Blelloch R. Embryonic stem cell-specific microRNAs promote induced pluripotency. Nat. Biotechnol. 2009, 27:459-461.
60. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 458:771-775.
61. Kamiya D., Banno S., Sasai N., Ohgushi M., Inomata H., Watanabe K., Kawada M., Yakura R., Kiyonari H., Nakao K., Jakt L.M., Nishikawa S., Sasai Y. Intrinsic transition of embryonic stem-cell differentiation into neural progenitors. Nature 2011, 470:503-509.
62. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009, 4:472-476.
63. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., Kim J., Aryee M.J., Ji H., Ehrlich L.I., Yabuuchi A., Takeuchi A., Cunniff K.C., Hongguang H., McKinney-Freeman S., Naveiras O., Yoon T.J., Irizarry R.A., Jung N., Seita J., Hanna J., Murakami P., Jaenisch R., Weissleder R., Orkin S.H., Weissman I.L., Feinberg A.P., Daley G.Q. Epigenetic memory in induced pluripotent stem cells. Nature 2010, 467:285-290.
64. Klimanskaya I., Hipp J., Rezai K.A., West M., Atala A., Lanza R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004, 6:217-245.
65. Kokkinaki M., Sahibzada N., Golestaneh N. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011, 29:825-835.
66. Koso H., Minami C., Tabata Y., Inoue M., Sasaki E., Satoh S., Watanabe S. CD73, a novel cell surface antigen that characterizes retinal photoreceptor precursor cells. Invest. Ophthalmol. Vis. Sci. 2009, 50:5411-5418.
67. Ku S., Soragni E., Campau E., Thomas E.A., Altun G., Laurent L.C., Loring J.F., Napierala M., Gottesfeld J.M. Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability. Cell Stem Cell 2010, 7:631-637.
68. Kurosawa H. Methods for inducing embryoid body formation: invitro differentiation system of embryonic stem cells. J.Biosci. Bioeng. 2007, 103:389-398.
69. Kuzmenkin A., Liang H., Xu G., Pfannkuche K., Eichhorn H., Fatima A., Luo H., Saric T., Wernig M., Jaenisch R., Hescheler J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells invitro. FASEB J. 2009, 23:4168-4180.
70. Lakowski J., Baron M., Bainbridge J., Barber A.C., Pearson R.A., Ali R.R., Sowden J.C. Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells. Hum. Mol. Genet. 2010, 19:4545-4559.
71. Lakowski J., Han Y.T., Pearson R.A., Gonzalez-Cordero A., West E.L., Gualdoni S., Barber A.C., Hubank M., Ali R.R., Sowden J.C. Effective transplantation of photoreceptor precursor cells selected via cell surface antigen expression. Stem Cells 2011, 29:1391-1404.
72. Lamba D.A., Karl M.O., Ware C.B., Reh T.A. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12769-12774.
73. Lamba D.A., Gust J., Reh T.A. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell 2009, 4:73-79.
74. Lamba D.A., McUsic A., Hirata R.K., Wang P.R., Russell D., Reh T.A. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 2010, 5:e8763.
75. Laurent L.C., Ulitsky I., Slavin I., Tran H., Schork A., Morey R., Lynch C., Harness J.V., Lee S., Barrero M.J., Ku S., Martynova M., Semechkin R., Galat V., Gottesfeld J., Izpisua Belmonte J.C., Murry C., Keirstead H.S., Park H.S., Schmidt U., Laslett A.L., Muller F.J., Nievergelt C.M., Shamir R., Loring J.F. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011, 8:106-118.
76. Lee H., Shamy G.A., Elkabetz Y., Schofield C.M., Harrsion N.L., Panagiotakos G., Socci N.D., Tabar V., Studer L. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25:1931-1939.
77. Li Y., Tsai Y.T., Hsu C.W., Erol D., Yang J., Wu W.H., Davis R.J., Egli D., Tsang S.H. Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa. Mol. Med. 2012, 18:1312-1319.
78. Liao J.L., Yu J., Huang K., Hu J., Diemer T., Ma Z., Dvash T., Yang X.J., Travis G.H., Williams D.S., Bok D., Fan G. Molecular signature of primary retinal pigment epithelium and stem-cell-derived RPE cells. Hum. Mol. Genet. 2010, 19:4229-4238.
79. Lin T., Ambasudhan R., Yuan X., Li W., Hilcove S., Abujarour R., Lin X., Hahm H.S., Hao E., Hayek A., Ding S. Achemical platform for improved induction of human iPSCs. Nat. Methods 2009, 6:805-808.
80. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:2883-2888.
81. Lu B., Malcuit C., Wang S., Girman S., Francis P., Lemieux L., Lanza R., Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
82. Lujan E., Wernig M. An imprinted signature helps isolate ESC-equivalent iPSCs. Cell Res. 2010, 20:974-976.
83. Lujan E., Chanda S., Ahlenius H., Sudhof T.C., Wernig M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:2527-2532.
84. MacLaren R.E., Pearson R.A., MacNeil A., Douglas R.H., Salt T.E., Akimoto M., Swaroop A., Sowden J.C., Ali R.R. Retinal repair by transplantation of photoreceptor precursors. Nature 2006, 444:203-207.
85. Mandai M., Ikeda H., Jin Z.B., Iseki K., Ishigami C., Takahashi M. Use of lectins to enrich mouse ES-derived retinal progenitor cells for the purpose of transplantation therapy. Cell Transplant. 2010, 19:9-19.
86. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. Amodel for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
87. Mattis V.B., Svendsen S.P., Ebert A., Svendsen C.N., King A.R., Casale M., Winokur S.T., Batugedara G., Vawter M., Donovan P.J., Lock L.F., Thompson L.M., Atwal R.S., Zhu Y., Fossale E., Gillis T., Mysore J., Li J.H., Seong I., Shen Y., Chen X., Wheeler V.C., MacDonald M.E., Gusella J.F., Akimov S., Arbez N., Juopperi T., Ratovitski T., Chiang J.H., Kim W.R., Chighladze E., Watkin E., Zhong C., Makri G., Cole R.N., Margolis R.L., Song H., Ming G., Ross C.A., Kaye J.A., Daub A., Sharma P., Mason A.R., Finkbeiner S., Rushton D., Brazier S.P., Battersby A.A., Redfern A., Tseng H.E., Harrison A.W., Kemp P.J., Allen N.D., Castiglioni V., Onorati M., Cattaneo E., Yu J., Thomson J.A., Arjomand J. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 2012, 11:264-278.
88. McGill T.J., Lund R.D., Douglas R.M., Wang S., Lu B., Silver B.D., Secretan M.R., Arthur J.N., Prusky G.T. Syngeneic Schwann cell transplantation preserves vision in RCS rat without immunosuppression. Invest. Ophthalmol. Vis. Sci. 2007, 48:1906-1912.
89. McLellan F. NIH director reviews first year on the job. "Roadmap" calls for reorganisation of basic and clinical research. Lancet 2003, 362:381-382.
90. McUsic A.C., Lamba D.A., Reh T.A. Guiding the morphogenesis of dissociated newborn mouse retinal cells and hES cell-derived retinal cells by soft lithography-patterned microchannel PLGA scaffolds. Biomaterials 2012, 33:1396-1405.
91. Mekhoubad S., Bock C., de Boer A.S., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 2012, 10:595-609.
92. Mellough C.B., Sernagor E., Moreno-Gimeno I., Steel D.H., Lako M. Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells 2012, 30:673-686.
93. Meyer J.S., Shearer R.L., Capowski E.E., Wright L.S., Wallace K.A., McMillan E.L., Zhang S.C., Gamm D.M. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16698-16703.
94. Meyer J.S., Howden S.E., Wallace K.A., Verhoeven A.D., Wright L.S., Capowski E.E., Pinilla I., Martin J.M., Tian S., Stewart R., Pattnaik B., Thomson J.A., Gamm D.M. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 2011, 29:1206-1218.
95. Mikkelsen T.S., Hanna J., Zhang X., Ku M., Wernig M., Schorderet P., Bernstein B.E., Jaenisch R., Lander E.S., Meissner A. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454:49-55.
96. Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., Dorn T., Goedel A., Hohnke C., Hofmann F., Seyfarth M., Sinnecker D., Schomig A., Laugwitz K.L. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N.Engl. J. Med. 2010, 363:1397-1409.
97. MRC Translational Research Initiative 2013.
98. Munoz-Sanjuan I., Brivanlou A.H. Neural induction, the default model and embryonic stem cells. Nat. Rev. Neurosci. 2002, 3:271-280.
99. Nakanishi M., Otsu M. Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine. Curr. Gene Ther. 2012, 12:410-416.
100. Nakano T., Ando S., Takata N., Kawada M., Muguruma K., Sekiguchi K., Saito K., Yonemura S., Eiraku M., Sasai Y. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012, 10:771-785.
101. Nasonkin I.O., Merbs S.L., Lazo K., Oliver V.F., Brooks M., Patel K., Enke R.A., Nellissery J., Jamrich M., Le Y.Z., Bharti K., Fariss R.N., Rachel R.A., Zack D.J., Rodriguez-Boulan E.J., Swaroop A. Conditional knockdown of DNA methyltransferase 1 reveals a key role of retinal pigment epithelium integrity in photoreceptor outer segment morphogenesis. Development 2013, 140:1330-1341.
102. Nguyen M., Arnheiter H. Signaling and transcriptional regulation in early mammalian eye development: a link between FGF and MITF. Development 2000, 127:3581-3591.
103. Okita K., Nagata N., Yamanaka S. Immunogenicity of induced pluripotent stem cells. Circ. Res. 2011, 109:720-721.
104. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
105. Osakada F., Ikeda H., Mandai M., Wataya T., Watanabe K., Yoshimura N., Akaike A., Sasai Y., Takahashi M. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat. Biotechnol. 2008, 26:215-224.
106. Osakada F., Jin Z.B., Hirami Y., Ikeda H., Danjyo T., Watanabe K., Sasai Y., Takahashi M. Invitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J.Cell Sci. 2009, 122:3169-3179.
107. Pearson R.A., Barber A.C., West E.L., MacLaren R.E., Duran Y., Bainbridge J.W., Sowden J.C., Ali R.R. Targeted disruption of outer limiting membrane junctional proteins (Crb1 and ZO-1) increases integration of transplanted photoreceptor precursors into the adult wild-type and degenerating retina. Cell Transplant. 2010, 19:487-503.
108. Pearson R.A., Barber A.C., Rizzi M., Hippert C., Xue T., West E.L., Duran Y., Smith A.J., Chuang J.Z., Azam S.A., Luhmann U.F., Benucci A., Sung C.H., Bainbridge J.W., Carandini M., Yau K.W., Sowden J.C., Ali R.R. Restoration of vision after transplantation of photoreceptors. Nature 2012, 485:99-103.
109. Peng S., Lacerda A.E., Kirsch G.E., Brown A.M., Bruening-Wright A. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes. J.Pharmacol. Toxicol. Methods 2010, 61:277-286.
110. Phillips M.J., Wallace K.A., Dickerson S.J., Miller M.J., Verhoeven A.D., Martin J.M., Wright L.S., Shen W., Capowski E.E., Percin E.F., Perez E.T., Zhong X., Canto-Soler M.V., Gamm D.M. Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest. Ophthalmol. Vis. Sci. 2012, 53:2007-2019.
111. Pomp O., Dreesen O., Leong D.F., Meller-Pomp O., Tan T.T., Zhou F., Colman A. Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 2011, 9:156-165.
112. Prather R.S., Sims M.M., First N.L. Nuclear transplantation in early pig embryos. Biol. Reprod. 1989, 41:414-418.
113. Ramalho-Santos J. Human procreation in unchartered territory: new twists in ethical discussions. Hum. Reprod. 2011, 26:1284-1287.
114. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1134-1140.
115. Robertson N.J., Brook F.A., Gardner R.L., Cobbold S.P., Waldmann H., Fairchild P.J. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20920-20925.
116. Rowland T.J., Buchholz D.E., Clegg D.O. Pluripotent human stem cells for the treatment of retinal disease. J.Cell. Physiol. 2012, 227:457-466.
117. Schwartz S.D., Hubschman J.P., Heilwell G., Franco-Cardenas V., Pan C.K., Ostrick R.M., Mickunas E., Gay R., Klimanskaya I., Lanza R. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 2012, 379:713-720.
118. Sheng C., Zheng Q., Wu J., Xu Z., Wang L., Li W., Zhang H., Zhao X.Y., Liu L., Wang Z., Guo C., Wu H.J., Liu Z., He S., Wang X.J., Chen Z., Zhou Q. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell Res. 2012, 22:208-218.
119. Sheridan S.D., Theriault K.M., Reis S.A., Zhou F., Madison J.M., Daheron L., Loring J.F., Haggarty S.J. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 2011, 6:e26203.
120. Singh R., Shen W., Kuai D., Martin J.M., Guo X., Smith M.A., Perez E.T., Phillips M.J., Simonett J.M., Wallace K.A., Verhoeven A.D., Capowski E.E., Zhang X., Yin Y., Halbach P.J., Fishman G.A., Wright L.S., Pattnaik B.R., Gamm D.M. iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum. Mol. Genet. 2013, 22:593-607.
121. Si-Tayeb K., Noto F.K., Sepac A., Sedlic F., Bosnjak Z.J., Lough J.W., Duncan S.A. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 2010, 10:81.
122. Smith J.R., Vallier L., Lupo G., Alexander M., Harris W.A., Pedersen R.A. Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev. Biol. 2008, 313:107-117.
123. Smukler S.R., Runciman S.B., Xu S., van der Kooy D. Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J.Cell Biol. 2006, 172:79-90.
124. Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., Isacson O., Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136:964-977.
125. Somers A., Jean J.C., Sommer C.A., Omari A., Ford C.C., Mills J.A., Ying L., Sommer A.G., Jean J.M., Smith B.W., Lafyatis R., Demierre M.F., Weiss D.J., French D.L., Gadue P., Murphy G.J., Mostoslavsky G., Kotton D.N. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010, 28:1728-1740.
126. Sonoda S., Spee C., Barron E., Ryan S.J., Kannan R., Hinton D.R. Aprotocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat. Protoc. 2009, 4:662-673.
127. Sridhar A., Steward M.M., Meyer J.S. Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells. Stem Cells Transl. Med. 2013, 2:255-264.
128. Stacpoole S.R., Bilican B., Webber D.J., Luzhynskaya A., He X.L., Compston A., Karadottir R., Franklin R.J., Chandran S. Derivation of neural precursor cells from human ES cells at 3% O(2) is efficient, enhances survival and presents no barrier to regional specification and functional differentiation. Cell Death Differ. 2011, 18:1016-1023.
129. Stadtfeld M., Apostolou E., Ferrari F., Choi J., Walsh R.M., Chen T., Ooi S.S., Kim S.Y., Bestor T.H., Shioda T., Park P.J., Hochedlinger K. Ascorbic acid prevents loss of Dlk1-Dio3 imprinting and facilitates generation of all-iPS cell mice from terminally differentiated B cells. Nat Genet 2012, 44. 398-405, S391-S392.
130. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322:945-949.
131. Strunnikova N.V., Maminishkis A., Barb J.J., Wang F., Zhi C., Sergeev Y., Chen W., Edwards A.O., Stambolian D., Abecasis G., Swaroop A., Munson P.J., Miller S.S. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum. Mol. Genet. 2010, 19:2468-2486.
132. Szabo E., Rampalli S., Risueno R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., Levadoux-Martin M., Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468:521-526.
133. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
134. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
135. Tchieu J., Kuoy E., Chin M.H., Trinh H., Patterson M., Sherman S.P., Aimiuwu O., Lindgren A., Hakimian S., Zack J.A., Clark A.T., Pyle A.D., Lowry W.E., Plath K. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010, 7:329-342.
136. Thier M., Worsdorfer P., Lakes Y.B., Gorris R., Herms S., Opitz T., Seiferling D., Quandel T., Hoffmann P., Nothen M.M., Brustle O., Edenhofer F. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012, 10:473-479.
137. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
138. Tropepe V., Hitoshi S., Sirard C., Mak T.W., Rossant J., van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001, 30:65-78.
139. Tucker B.A., Scheetz T.E., Mullins R.F., DeLuca A.P., Hoffmann J.M., Johnston R.M., Jacobson S.G., Sheffield V.C., Stone E.M. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E569-E576.
140. Tucker B.A., Anfinson K.R., Mullins R.F., Stone E.M., Young M.J. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl. Med. 2013, 2:16-24.
141. Ukrohne T.U., Westenskow P.D., Kurihara T., Friedlander D.F., Lehmann M., Dorsey A.L., Li W., Zhu S., Schultz A., Wang J., Siuzdak G., Ding S., Friedlander M. Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl. Med. 2012, 1:96-109.
142. Urbach A., Bar-Nur O., Daley G.Q., Benvenisty N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6:407-411.
143. Utikal J., Maherali N., Kulalert W., Hochedlinger K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J.Cell Sci. 2009, 122:3502-3510.
144. Vaajasaari H., Ilmarinen T., Juuti-Uusitalo K., Rajala K., Onnela N., Narkilahti S., Suuronen R., Hyttinen J., Uusitalo H., Skottman H. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol. Vis. 2011, 17:558-575.
145. Vallier L., Alexander M., Pedersen R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J.Cell Sci. 2005, 118:4495-4509.
146. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Sudhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041.
147. Vugler A., Carr A.J., Lawrence J., Chen L.L., Burrell K., Wright A., Lundh P., Semo M., Ahmado A., Gias C., da Cruz L., Moore H., Andrews P., Walsh J., Coffey P. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp. Neurol. 2008, 214:347-361.
148. Wang S., Girman S., Lu B., Bischoff N., Holmes T., Shearer R., Wright L.S., Svendsen C.N., Gamm D.M., Lund R.D. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:3201-3206.
149. Wang T., Chen K., Zeng X., Yang J., Wu Y., Shi X., Qin B., Zeng L., Esteban M.A., Pan G., Pei D. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011, 9:575-587.
150. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7:618-630.
151. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., Staerk J., Markoulaki S., Jaenisch R. Adrug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 2008, 26:916-924.
152. West E.L., Pearson R.A., Tschernutter M., Sowden J.C., MacLaren R.E., Ali R.R. Pharmacological disruption of the outer limiting membrane leads to increased retinal integration of transplanted photoreceptor precursors. Exp. Eye Res. 2008, 86:601-611.
153. West E.L., Pearson R.A., Barker S.E., Luhmann U.F., Maclaren R.E., Barber A.C., Duran Y., Smith A.J., Sowden J.C., Ali R.R. Long-term survival of photoreceptors transplanted into the adult murine neural retina requires immune modulation. Stem Cells 2010, 28:1997-2007.
154. West E.L., Gonzalez-Cordero A., Hippert C., Osakada F., Martinez-Barbera J.P., Pearson R.A., Sowden J.C., Takahashi M., Ali R.R. Defining the integration capacity of embryonic stem cell-derived photoreceptor precursors. Stem Cells 2012, 30:1424-1435.
155. Williams D.S., Lopes V.S. The many different cellular functions of MYO7A in the retina. Biochem. Soc. Trans. 2011, 39:1207-1210.
156. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
157. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hamalainen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
158. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin, Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
159. Yusa K., Rashid S.T., Strick-Marchand H., Varela I., Liu P.Q., Paschon D.E., Miranda E., Ordonez A., Hannan N.R., Rouhani F.J., Darche S., Alexander G., Marciniak S.J., Fusaki N., Hasegawa M., Holmes M.C., Di Santo J.P., Lomas D.A., Bradley A., Vallier L. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011, 478:391-394.
160. Zhang B. CD73: a novel target for cancer immunotherapy. Cancer Res. 2010, 70:6407-6411.
161. Zhang K., Liu G.H., Yi F., Montserrat N., Hishida T., Rodriguez Esteban C., Izpisua Belmonte J.C. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell 2013, [Epub ahead of print].
162. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
163. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., Siuzdak G., Scholer H.R., Duan L., Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4:381-384.
164. Zhou L., Wang W., Liu Y., Fernandez de Castro J., Ezashi T., Telugu B.P., Roberts R.M., Kaplan H.J., Dean D.C. Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina. Stem Cells 2011, 29:972-980.
165. Zhou W., Freed C.R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27:2667-2674.
166. Zou J., Maeder M.L., Mali P., Pruett-Miller S.M., Thibodeau-Beganny S., Chou B.K., Chen G., Ye Z., Park I.H., Daley G.Q., Porteus M.H., Joung J.K., Cheng L. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 2009, 5:97-110.